In recent years, Canadian investors have faced challenges with investing in cannabis stocks due to various factors such as the prevalence of black market sales and obstacles in the international market. However, despite the current uncertainties, the cannabis industry is poised for future growth.
One company that stands out in this evolving market is Organigram Holdings (TSX:OGI). Organigram has had a successful year thus far, with a significant investment from British American Tobacco helping to mitigate risks and fund strategic initiatives, such as the development of Jupiter, a strategic investment pool targeting emerging cannabis markets.
The partnership with British American Tobacco also highlights Organigram’s focus on expanding globally and positioning itself for growth, particularly in the United States. By learning from the mistakes of competitors and focusing on higher-margin segments of the market, Organigram is well-positioned to capitalize on the evolving landscape of the cannabis industry.
Despite reporting a first quarter loss, Organigram remains optimistic about its future growth potential, with analysts projecting revenue growth and improved profitability in the coming years. With shares trading at a discount and a potential upside, Organigram stock presents an attractive opportunity for investors seeking exposure to the cannabis sector.
